AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Biotech, Regulation, and Public Health Implications
This chapter explores the implications of the new FDA head's biotech policies and the favorable response from the biotech industry, juxtaposed with health advocates' concerns over expedited drug approvals. It critiques fear-driven public health policies and the historical context of pharmaceutical industry deregulation, particularly in light of past crises like bird flu and the COVID-19 pandemic.